세계의 유방조영술 시장 보고서(2025년)
Mammography Global Market Report 2025
상품코드 : 1824291
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 유방조영술 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 복합 성장률(CAGR)은 10.0%로 확대되어 42억 2,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 맞춤형 의료에 대한 접근, 유방암 검진 프로그램의 확대, 조사에 있어서의 공동 연구 증가, 원격 의료와 원격 검진, 환자 중심의 케어에의 주력 등에 기인합니다. 예측기간의 주요 동향으로는 디지털 유방조영의 우위성, 3D 유방조영(토모신세시스)의 대두, 인공지능의 통합, 개별화 검진 중시, 암 검진 이외의 용도 확대, 유방 영상 기술 진보 등을 들 수 있습니다.

향후 5년간의 성장률을 10.0%로 예측한 것은 지난 예측으로부터 0.2% 소폭 감소를 반영한 것입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 한국과 이스라엘에서 조달한 디지털 유방 토모신세시스 시스템과 인공지능(AI) 지원 진단 소프트의 가격을 끌어올려 영상 진단센터의 경비를 악화시켜 암의 조기 발견을 늦추는 것으로 미국 환자에게 부담을 줄 가능성이 높습니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 가해질 수 있습니다.

유방 조영술 시장의 성장은 유방암 이환율 증가에 의해 촉진될 것으로 예측됩니다. 유방암은 유방 내의 무질서한 세포 증식을 특징으로 하며, 세계적으로 증가하는 경향이 있습니다. 유방 조영술은 매우 영향력있고 널리 사용되는 스크리닝 도구이기 때문에 유방암의 조기 발견과 진단에 중요한 역할을합니다. 예를 들어 미국을 거점으로 하는 비영리단체인 Breastcancer.org는 2023년에 미국 여성의 침윤성 유방암의 신규 증례 수는 약 29만 7,790례, DCIS의 신규 증례 수는 5만 5,720례로 추정하고 있습니다. 2023년 1월 미국암 협회가 2022년 미국에서 침윤성 유방암의 신규 발생수는 28만 7,850례, 비침윤성(in situ) 유방암의 신규 발생수는 5만 1,400례로 보고하고 있듯이 유방암의 유병률은 분명합니다. 그 결과 유방암의 이환율 증가가 유방 조영술 시장 성장의 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Mammography serves as a diagnostic X-ray imaging method employed to examine breast tissue for the early detection of malignancies, breast cancer, and other breast ailments. It serves dual purposes as both a screening and diagnostic tool.

Film screen systems, digital systems, analog systems, biopsy systems, 3D systems, and various others constitute the primary types of mammography products. Film screen mammography, a technique within this array, captures images of breast tissue on X-ray film and archives them. This method entails compressing the breast between two plates, subjecting it to X-rays, and developing the resultant image on specialized film.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The mammography market research report is one of a series of new reports from The Business Research Company that provides mammography market statistics, including mammography industry global market size, regional shares, competitors with a mammography market share, detailed mammography market segments, market trends and opportunities, and any further data you may need to thrive in the mammography industry. This mammography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mammography market size has grown strongly in recent years. It will grow from $2.63 billion in 2024 to $2.88 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing breast cancer incidence, rising awareness and screening programs, government initiatives and funding, advocacy and support groups, improved reimbursement policies.

The mammography market size is expected to see strong growth in the next few years. It will grow to $4.22 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to personalized medicine approaches, expansion of breast cancer screening programs, increasing collaboration in research, telemedicine and remote screening, focus on patient-centric care. Major trends in the forecast period include digital mammography dominance, rise of 3d mammography (tomosynthesis), integration of artificial intelligence, increasing emphasis on personalized screening, expanding applications beyond cancer screening, advancements in breast imaging technologies.

The forecast of 10.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of digital breast tomosynthesis systems and Artificial intelligence(AI)-assisted diagnostic software sourced from South Korea and Israel, exacerbating imaging center expenses and delaying early cancer detection. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the mammography market is anticipated to be propelled by the increasing incidence of breast cancer. Breast cancer, characterized by the uncontrolled proliferation of cells in the breast, is on the rise globally. Mammography, being a highly influential and widely utilized screening tool, plays a crucial role in the early detection and diagnosis of breast cancer. For instance, in 2023, it is projected that Breastcancer.org, a US-based nonprofit organization, estimates approximately 297,790 new cases of invasive breast cancer and 55,720 new cases of DCIS in U.S. women. The prevalence of breast cancer is evident, as in January 2023, the American Cancer Society reported 287,850 new instances of invasive breast cancer and 51,400 new cases of non-invasive (in situ) breast cancer in the United States for the year 2022. Consequently, the increasing incidence of breast cancer is a driving force behind the growth of the mammography market.

The growth of the mammography market is further fueled by the rising demand for early-stage diagnosis among patients. Early-stage diagnosis involves identifying and detecting diseases at their initial phases, often before noticeable symptoms manifest or the disease progresses. Mammography is integral to early-stage diagnosis due to its capability to detect breast abnormalities, such as tumors or calcifications, at the initial stages. This facilitates timely intervention, leading to improved treatment outcomes by enabling early intervention and reducing the risk of advanced breast cancer development. For instance, in October 2022, the National Health Service (NHS) England reported that more than 100,000 patients received a cancer diagnosis during stages one or two in the past year (2021-2022), representing the largest proportion ever diagnosed at more treatable stages. Hence, the increasing demand for early-stage diagnosis is a significant driver of the mammography market.

Technological advancement is a significant trend gaining traction in the mammography market. Major players in this sector are concentrating on innovative technologies to enhance their market position. For example, in November 2023, GE HealthCare, a U.S.-based healthcare company, launched the MyBreastAI Suite, an advanced AI-powered platform aimed at improving breast cancer detection and optimizing radiology workflows. This suite features three key applications from iCAD, a leader in AI cancer detection, representing a significant leap in breast imaging technology. By incorporating iCAD's AI capabilities, GE HealthCare seeks to enhance clinical decision support, boost diagnostic accuracy, and streamline radiology workflows. This innovation addresses challenges such as increasing imaging volumes and workforce shortages, ultimately contributing to improved patient outcomes. Given that breast cancer is the most frequently diagnosed cancer worldwide, these advancements are crucial for early detection and effective treatment.

Major companies in the mammography market are concentrating on initiatives such as pilot programs to enhance early breast cancer detection, improve patient outcomes, and expand access to underserved populations through mobile screening units and AI-driven diagnostic tools. These efforts aim to increase accuracy, shorten diagnostic times, and make mammography more accessible in remote and economically disadvantaged areas, ultimately promoting better healthcare equity. For example, in December 2023, RadNet, Inc., a U.S.-based healthcare company, launched a pilot program called MammogramNow, which provides mammography services within Walmart Supercenters. This initiative seeks to raise breast health awareness and accessibility by incorporating advanced DeepHealth AI technology into a retail environment, thereby making breast cancer screening more convenient. MammogramNow allows for walk-in appointments, with screenings taking about 15 minutes to complete. Patients also have the option for AI-enhanced screenings through RadNet's DeepHealth subsidiary to improve detection accuracy. By integrating healthcare services into everyday retail spaces, RadNet and Walmart aim to transform the delivery and accessibility of preventive healthcare in the U.S.

In April 2024, Solis Mammography, a U.S.-based healthcare company, formed a partnership with Northwest Healthcare to enhance breast imaging services in the Tucson area. This collaboration seeks to improve access to essential mammography services, which are vital for early breast cancer detection, particularly for women over 40, who are at greater risk. Northwest Healthcare is also a U.S.-based organization dedicated to delivering high-quality, accessible healthcare to the local community, thereby reinforcing the objectives of this initiative.

Major companies operating in the mammography market include Hologic Inc., Fujifilm Corporation, Siemens Healthcare AG, Canon Medical Systems Corporation, GE Healthcare Company, Metaltronica S.p.A, Koninklijke Philips N.V., Gamma Medica Inc., Konica Minolta Inc., Carestream Health, PLANMED OY, Villa Sistemi Medicali Spa., Toshiba Medical Systems Corporation, Allengers Medical Systems Ltd., Analogic Corporation, IMS Srl, BMI Biomedical International s.r.l., General Medical Merate S.p.A., Genoray Co. Ltd., Agfa-Gevaert N.V., Delphinus Medical Technologies Inc., Micrima Limited, CMR Naviscan Corporation, Dilon Technologies Inc., Koning Corporation, Medi-Future Co. Ltd., PerkinElmer Inc., QView Medical Inc., Radmirtech Co. Ltd., SOREDEX, Trivitron Healthcare Pvt. Ltd., Ziehm Imaging GmbH, Zonare Medical Systems Inc.

North America was the largest region in the mammography market in 2024. The regions covered in the mammography market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the mammography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The mammography market includes revenues earned by entities by screening mammography, diagnostic mammography, digital mammography, and breast ultrasound. The market value includes the value of related goods sold by the service provider or included within the service offering. The mammography market also includes sales of mammography machines, compression paddles and radiographic films. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammography Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mammography market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for mammography ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mammography market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Mammography Market Characteristics

3. Mammography Market Trends And Strategies

4. Mammography Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Mammography Growth Analysis And Strategic Analysis Framework

6. Mammography Market Segmentation

7. Mammography Market Regional And Country Analysis

8. Asia-Pacific Mammography Market

9. China Mammography Market

10. India Mammography Market

11. Japan Mammography Market

12. Australia Mammography Market

13. Indonesia Mammography Market

14. South Korea Mammography Market

15. Western Europe Mammography Market

16. UK Mammography Market

17. Germany Mammography Market

18. France Mammography Market

19. Italy Mammography Market

20. Spain Mammography Market

21. Eastern Europe Mammography Market

22. Russia Mammography Market

23. North America Mammography Market

24. USA Mammography Market

25. Canada Mammography Market

26. South America Mammography Market

27. Brazil Mammography Market

28. Middle East Mammography Market

29. Africa Mammography Market

30. Mammography Market Competitive Landscape And Company Profiles

31. Mammography Market Other Major And Innovative Companies

32. Global Mammography Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mammography Market

34. Recent Developments In The Mammography Market

35. Mammography Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기